Japan Antibiotics Research Association Compendium of Rules 9-2

The Japanese Journal of Antibiotics
Instructions for Authors
The Japanese Journal of Antibiotics (“JJA”) is an open access quarterly online journal,
publishing articles written in Japanese or English, and accessible to the public immediately
after publication.
JJA contains articles and reports on anti-infective drugs (antibacterial, antifungal,antiviral and other agents including vaccines), infection control (including for experimental
infections) or bacteriological testing (testing techniques).
Categories of articles
1. There are seven categories of articles published in JJA:
A. Original Articles: Articles including innovative and valuable knowledge derived fromresearch results, etc.
B. Case Reports: Articles on cases
C. Brief Reports: Articles that are insufficient to meet the criteria of original articles dueto the limited number of cases investigated but include innovative and valuableknowledge and discussion
D. Research Reports: Articles that do not meet the criteria of original articles but
contain insights worth publishing
E. Review Articles: Articles that summarize research results on a specific theme withadequate experimental evidence and conclusions
F. Reference Materials: Papers containing data compiled from research andinvestigation, or articles intended to share information
G. Proceedings: Lectures at a conference/seminar or records of a symposium orconversation
Paper writing
2. Refer to “How to Write a Scientific Paper for the Japanese Journal of Antibiotics” inAppendix on page 5.
3. Original Articles, Case Reports, Brief Reports and Research Reports are eligible forpublication provided that their main arguments have not been published in anotherjournal.
Submission of manuscripts
4. Manuscripts (main text, tables and figures, etc.), accompanied by the Transparency
Declaration and Affirmation of Originality and Assignment of Copyright forms, should besent via e-mail to the JJA Editorial Office (jja@antibiotics.or.jp). The Transparency
Declaration and Affirmation of Originality and Assignment of Copyright forms should besigned by the corresponding author and scanned before being sent.
5. For any manuscript containing materials not copyrighted by the authors or alreadypublished, the authors need to secure authorization for reprint from the copyright holder(and publisher) concerned. In submitting the manuscript, a copy of the written
authorization for reprint shall be attached for each of the reprinted materials.
6. When submitting a manuscript in English, the English text should be edited by an expert
prior to submission. Where the authors request the JJA Editorial Office for English
proofreading, the authors must bear the cost of the service.
7. The receipt date shall be the date when the Editorial Office receives the email with themanuscript file attached.
Review of manuscripts
8. The Editorial Board is responsible for the final decision regarding acceptance or rejectionof articles. Manuscripts shall be subject to peer review in principle.
9. Manuscripts passing the initial screening by the Editorial Board shall be reviewed by the1Japan Antibiotics Research Association Compendium of Rules 9-2
referees designated by the Editorial Board. When it is decided that the manuscript
requires revision, the authors shall re-submit the revised manuscript within the prescribedperiod of time. The Editor-in-Chief of the Editorial Board shall make the final decision on
the publication of each manuscript.
Proofreading of articles
10. The first proof shall be the text proofread by the authors.
Copyright11. The copyright of articles published in JJA belongs to the Japan Antibiotics Research
Association (“JARA”).
12. The authors shall sign the Affirmation of Originality and Assignment of Copyright form toassign all types of copyright to the publications in JJA to JARA.
Open access and Creative Commons (CC) License
13. All articles and papers published in JJA are open access materials. “Open Access”
means ensuring unhindered access for the public by making available articles and papers
free of charge on the Internet and clearly stating the scope and conditions for secondary
use including copying, reprint or translation (license information).
14. JJA’s standard license regarding its policy for secondary use shall be Creative Commons
License (https://creativecommons.org/share-your-work/cclicenses/) CC BY 4.0, but other
CC Licenses (CC BY-ND 4.0, CC BY-NC 4.0 and CC BY-NC-ND 4.0) may be selected
as necessary. The authors shall tick the box of the appropriate CC license in theAffirmation of Originality and Assessment of Copyright form, which must be duly signed.
Further details of CC licenses follow.
[CC BY 4.0] (recommended by JARA)
The authors decide to choose CC License CC BY 4.0 (Attribution 4.0 International).
This license allows the sharing and modification (including adaptation) of the article
for both commercial and non-commercial purposes, provided that appropriate credit
is given (including indication of modifications, if any).
[CC BY-ND 4.0]
The authors decide to choose CC License CC BY-ND 4.0 (Attribution – No
Derivatives 4.0 International). This license allows the sharing of the non-modified
article for both commercial and non-commercial purposes, provided thatappropriate credit is given.
[CC BY-NC 4.0]
The authors decide to choose CC License CC BY-NC 4.0 (Attribution – NonCommercial 4.0 International). This license allows the sharing and modification(including adaptation) of the article for only non-commercial purposes, provided thatappropriate credit is given (including indication of modifications, if any).
[CC BY-NC-ND 4.0]
The authors decide to choose CC License CC BY-NC-ND 4.0 (Attribution – NonCommercial No Derivatives 4.0 International). This license allows the sharing of thenon-modified article for only non-commercial purposes, provided that appropriate
credit is given.
When the authors make no choice, the CC License shall default to CC BY 4.0. Nochange or cancellation may be made once a CC License has been given*.
*Some sponsoring organizations require that the sponsored articles be made public

under a specific CC License. It is the authors’ responsibility to check with any sponsoringorganization before submitting the manuscript.
Ethics
15. Research or study involving human subjects shall be conducted in compliance with the2Japan Antibiotics Research Association Compendium of Rules 9-2
ethical standards under the Declaration of Helsinki and shall comply with the EthicalGuidelines for Life Science and Medical Research Involving Human Subjects of theMinistry of Education, Culture, Sports, Science and Technology, the Ministry of Health,Labour and Welfare and the Ministry of Economy, Trade and Industry of Japan, or shallmeet any equivalent institutional standards. Articles on clinical trials shall include thename of the clinical trial register system, registration number, etc.
16. Clinical research on genetic therapies shall comply with the Guidelines for ClinicalResearch on Genetic Therapies or shall meet any equivalent institutional standards.
17. Animal experiments must be performed with reference to guidelines for appropriate
implementation from the perspective of animal protection and in accordance withapplicable scientific and ethical norms, while complying with institutional guidelines.
18. Elsewhere, research shall meet applicable guidance or relevant ministerialorders/guidelines, or meet any equivalent institutional standards, with reference to the
List of Guidelines on Medical Research published by the Ministry of Health, Labour andWelfare(https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/ikenkyu/index.html), among others.
Conflict of interest (COI)
19. All authors shall disclose COI arising from any financial affiliation (annual payment of¥1,000,000 or more from any single company or organization, or in the case of a lecture
or manuscript fee, annual payment totaling ¥500,000 or more from a single company ororganization) or personal affiliation. The lead author shall check the COI status of allother authors and fill in the Transparency Declaration form, which must be duly signed.
Anything that warrants self-declaration, or the absence thereof, should be indicated atthe end of the manuscript.
Manuscript publication charges
20. Manuscript publication charges are as follows.
(1) Page charge
There is no charge for up to three pages for an original article, research report orreference material, and up to two pages for a case or brief report. Where themanuscript exceeds those limits, the authors are required to pay a charge of ¥16,500(tax included) per page. Color prints of pictures, figures and tables shall be provided
free of charge.
(2) Reviewing charge
Reviewing is basically free of charge. The authors shall pay any special extra costthat is required and to which they consent.
(3) Offprints
Offprints are available at cost. The authors may order the required number of copies
in units of 50 at the time of their own proofreading.
Address
21. Manuscripts should be sent to the following address:
The Japanese Journal of Antibiotics Editorial Office
Japan Antibiotics Research Association
jja@antibiotics.or.jp
Supplementary provisions
Effective on 1 April 1983 (as internal rules)
Revised on 22 September 1998
Revised on 25 May 2009
Revised on 3 December 2010
Revised on 15 March 2013
Revised on 1 November 2014
Revised on 1 April 20173

Japan Antibiotics Research Association Compendium of Rules 9-2
Revised on 6 November 2017
Revised on 18 March 2019
Revised on 1 September 2019
Revised on 25 March 2020
Revised on 30 April 2020
Revised on 14 October 2020
Revised on 1 October 2024

4

Japan Antibiotics Research Association Compendium of Rules 9-2

Appendix to the Instructions for Authors:
How to Write a Scientific Paper for the Japanese Journal of Antibiotics
1. The paper should adopt one of the following formats: (A) Original Article; (B) Case Report;(C) Brief Report; (D) Research Report; (E) Review Article; (F) Reference Material; or (G)Proceedings.
2. Although there are no limitations on the number of words, figures or tables, the article
should be written clearly and concisely.
3. The manuscript should be written in Japanese or English. Japanese text should use
Chinese characters in common use and contemporary Japanese syllabic writing. Also,in the case of a Japanese manuscript, the first letter of every English word in the text
should be capitalized. Terms should be consistent throughout the manuscript. The files
should be provided in Word, PowerPoint, and/or Excel format. The font size should be
12 points in general. Indicate the position of figures and tables in the text.
4. JJA is published in B5-size format, which means that figures and tables should be nolarger than 15 cm (W) x 21 cm (H). Figures and tables should be drawn in balanced
dimensions both horizontally and vertically taking account of the size of the journal, sothat they remain legible when reduced in scale.
5. Use Arabic numerals and standard metric units as below for length, weight, and volume:
km, m, cm, mm, μm, nm, m2, L, dL, mL, μL, kg, g, mg, μg, ng, pg, hr, min, sec, IU, mol,mmol, %, °C, mmHg, etc.
6. Italics should be used for scientific names. Names of fungi, drugs, diseases, etc. should
not be abbreviated. When any abbreviation is used, indicate it in the text. If a fungus
name is spelled out at its first appearance (e.g., Staphylococcus aureus), the genericname may subsequently be abbreviated to the first letter (e.g., S. aureus).
7. References should be listed in numerical order at the end of the manuscript. Do notabbreviate Japanese journal names. Abbreviations for titles of medical periodicals inother languages should conform to those used in Index Medicus and follow the Uniform
Requirements for Manuscripts Submitted to Biomedical Journals (so-called “Vancouver”style).
(1) Ōmura S, Tomoda H, Kim YK, Nishida H: Pyripyropenes, highly potent inhibitors ofACYL-CoA: cholesterol acyltransferase produced by Aspergillus fumigatus. J
Antibiot. 1993; 46: 1168-9.
All authors should be listed for papers with up to six authors; for papers with seven or
more authors, the first three authors should be listed, followed by et al.
Structure of the paper
Title page: Write the format and title of the article, the names and affiliations of the authors,
the signature and contact information of the corresponding author (including phone numberand e-mail address), and (up to five) keywords, in that order.
Abstract: Clearly and concisely state the essence of the research described in the article.
Introduction: Clearly describe the objective of research, citing literature related to thebackground for planning the research described in the article.
Materials and methods:

5Japan Antibiotics Research Association Compendium of Rules 9-2(1) For a tested strain, clearly indicate if it is a clinical isolate or a standard strain. For aclinical isolate, describe the conditions of sample collection.
(2) Clearly state that the research was carried out in compliance with appropriate ethicalstandards, as required for any research project.
Example: The research was conducted with the approval of the Ethics Committee ofXXX University (approval number: XXX).
(3) When describing a novel experimental procedure, provide sufficient technical details
so that it could be replicated. In case of partial change to a published procedure, cite
the original article, accompanied by a detailed description of the change concerned.
The original article should be cited if a published procedure was used without
modification.
(4) In case of a statistical analysis, clearly state the analytical procedure as well assoftware used for the analysis.
Results:(1) Only describe the results of research conducted by the authors, etc. in a concise
manner to avoid duplication in argument.
(2) Reserve the interpretation of the results for the discussion section.
(3) Any result derived from comparative studies between groups should be concisely
supported by statistical analysis.
(4) Make sure to include any negative but important results gained from the research.
Discussion: Do not repeat results in this section.
Conflict of interest:(1) No COI to report:
State: “There is no conflict of interest.”(2) Reporting of COI:
State, for example:“Declaration of conflict of interest:
Author A receives a scholarship from Company X.
Author B receives a lecture fee from Company Y.
Author C works for Company Z.”
References:(1) Add a series of numbers followed by a single parenthesis on the right of citations inthe text.
(2) References should appear in the order of citation in the text.
(3) In general, references should be limited to peer-reviewed articles.
Structure of the paper
Article format
Structure
A. Original Article (1) Title page; (2) Abstract; (3) Introduction; (4) Materials and methods;(5) Results; (6) Discussion; (7) Acknowledgements; (8) COI; (9)References; (10) [In case of an article in Japanese] Abstract in English(title, author names in alphabetic characters, affiliations, abstract); and(11) Figures/tables.
B. Case Report(1) Title page; (2) Abstract; (3) Introduction: (4) Case studies; (5)Discussion; (6) Acknowledgements; (7) COI; (8) References; (9) [Incase of an article in Japanese] Abstract in English (title, author names
in alphabetic characters, affiliations, abstract); and (10) Figures/tables.
C. Brief Report
In general: (1) Title page; (2) Abstract; Items 3, 4, 5 and 6 for originalarticles without distinction; (7) Acknowledgements; (8) COI; (9)References; (10) [In case of an article in Japanese] Abstract in English(title, author names in alphabetic characters, affiliations, abstract); and6

Japan Antibiotics Research Association Compendium of Rules 9-2

D. Research
Report
E. Review Article

F. Reference
MaterialG. Proceedings(11) Figures/tables.
Same as for original articles.
(1) Title page; (2) Abstract; (3) Introduction; (4) Results; (5)Acknowledgements; (6) COI; (7) References; (8) [In case of an article
in Japanese] Abstract in English (title, author names in alphabetic
characters, affiliations, abstract); and (9) Figures/tables.
In general: (1) Title page; (2) Abstract; (3) Introduction; (4) Methods;(5) Materials; (6) Discussion; (7) Acknowledgements; (8) COI; (9)References; (10) [In case of an article in English] Abstract in English(title, author names in alphabetic characters, affiliations, abstract); and(11) Figures/tables.
No prescribed structure7